May 02 2021 Read 9 Times
An investment of €1M ($1.2M) in a new pipeline of complex therapeutic targets and native antigens of high relevance for pharmaceutical companies has been announced by French biotech Calixar. This strategic investment, supported by Bpifrance investment bank, will enable the company to provide native and functional membrane therapeutic targets (GPCRs, ion channels, transporters, receptors and viral targets) and advance drugs and vaccines developments.
“Collective studies agree that the pharmaceutical industry needs to optimise its drug development model,” said Emmanuel Dejean, founder and CEO of Calixar. “In Calixar’s view, the problems faced in clinical development are related particularly to the unreliability of the therapeutic targets isolated upstream.”
A Drumheller woman was fined $1,000 after pleading guilty to possession of drugs.Jaime Ryan appeared in provincial court on Friday, April 9 via telephone connection where she pleaded guilty to posses
SHREVEPORT, La - Sheriff Steve Prator and Chief Ben Raymond announced today that the Caddo/Shreveport Narcotics Unit have successfully concluded a lengthy narcotics investigation. With the execution of several search warrants, the unit seized of 60 pounds of Marijuana, $56,070.00 in U.S. currency, and 5 firearms.
The following arrests were made in connection with the investigation:
Johnny Adger III, 37
Possession of a Firearm with a Controlled Dangerous Substance
Possession of a Firearm by a Convicted Felon
Debreyia Gray, 36
Possession of a Firearm with a Controlled Dangerous Substance Love